
Oceanpine Capital
Asia, Hong Kong Island, Hong Kong, Central'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Description
Oceanpine Capital invests in growth equity for innovative companies.
Investor Profile
Oceanpine Capital has backed more than 16 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 38% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Series A rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Biotechnology, Health Care, Biopharma.
Stage Focus
- Series C (44%)
- Series B (19%)
- Series A (19%)
- Series E (6%)
- Series Unknown (6%)
- Seed (6%)
Country Focus
- China (56%)
- United States (44%)
Industry Focus
- Biotechnology
- Health Care
- Biopharma
- Pharmaceutical
- Medical
- Manufacturing
- Artificial Intelligence (Ai)
- Semiconductor
- Electronics
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Oceanpine Capital frequently co-invest with?
What are some of recent deals done by Oceanpine Capital?
Find More Investors Like Oceanpine Capital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides










